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Abstract
The interplay between maturation-promoting factor (MPF), mitogen-activated protein kinase (MAPK) and Rho GTPase
during actin-myosin interactions has yet to be determined. The mechanism by which microtubule disrupters induce the
formation of ooplasmic protrusion during chemical-assisted enucleation of mammalian oocytes is unknown. Moreover, a
suitable model is urgently needed for the study of cytokinesis. We have established a model of chemical-induced
cytokinesis and have studied the signaling events leading to cytokinesis using this model. The results suggested that
microtubule inhibitors activated MPF, which induced actomyosin assembly (formation of ooplasmic protrusion) by
activating RhoA and thus MAPK. While MAPK controlled actin recruitment on its own, MPF promoted myosin enrichment by
activating RhoA and MAPK. A further chemical treatment of oocytes with protrusions induced constriction of the
actomyosin ring by inactivating MPF while activating RhoA. In conclusion, the present data suggested that the assembly
and contraction of the actomyosin ring were two separable steps: while an increase in MPF activity promoted the assembly
through RhoA-mediated activation of MAPK, a decrease in MPF activity triggered contraction of the ring by activating RhoA.
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Introduction
Cytokinesis is mediated by a dynamic interplay between the
microtubules of the mitotic spindle, the actomyosin cytoskeleton and
membrane fusion events [1]. For many decades, although morpho-
logical observations led to great insights into the cellular structures
that orchestrate cell division, the underlying molecular machinery is
largely unknown. While studies suggest that a local minimum of
microtubule density or microtubule depolymerization induces the
formation of contractile rings through activation of RhoA [2,3], how
RhoA is activated has yet to be determined. In addition, although
both the maturation-promoting factor (MPF) and mitogen-activated
protein kinase (MAPK) were found to regulate actin-myosin
interactions [4–6], interplay between these two kinases in this context
has not been reported. Furthermore, unlike other cell cycle events,
cytokinesis has been particularly resistant to in vitro biochemical
approaches, making research progress very slow [7]. A powerful in
vitro model is therefore urgently needed to dissect out the different
steps and molecules involved in cytokinesis.
During meiotic maturation of mammalian oocytes, the meiosis I
spindle first assembles around the centrally positioned chromo-
somes and then migrates to the cortex of the oocyte [8,9].
Meanwhile, an actin-rich but cortical granule- and microvillus-free
cortical domain develops over the eccentrically positioned meiotic
spindle [10–12]. While in most mitotic cells, the cues that direct
cell polarization are often extrinsic, coming from the environment
or certain cortical landmarks [13,14], the molecular cues for
asymmetric meiotic divisions of oocytes remain poorly understood.
Although studies suggested that the subcortically positioned
chromosomes in mouse oocytes [12,15,16], or the attachment of
spindle pole to the cortex of Xenopus oocytes [17,18], could
provide the necessary cue, and that the small GTPases [16–19]
might be involved, it is unknown how chromosomes or the spindle
pole attachment activate small GTPases during the establishment
of cortical polarity and assembly of a contractile ring.
A brief treatment of matured oocytes with microtubule disrupter
demecolcine results in a cytoplasmic protrusion containing a
condensed chromosome mass [20–22]. In goat oocytes with
demecolcine-induced ooplasmic protrusions the spindle disinte-
grated and a contractile ring formed around the condensed
chromosome mass [22]. When these oocytes were treated with
cytochalasin B, the contractile ring disappeared while the spindle
reintegrated. Therefore, we proposed that if the chemical-induced
ooplasmic protrusion can pinch off after a further appropriate
treatment, the goat oocyte could serve as an in vitro model for
study of cytokinesis. We have established such a model and have
studied the interactions between MPF, RhoA and MAPK on the
assembly (ooplasmic protrusion) and contraction (extrusion of
second polar bodies, Pb2) of the actomyosin ring using this model.
The results suggested that the assembly and contraction of the ring
were two separable steps: while an increase in MPF activities
promoted the assembly through RhoA-mediated activation of
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12706MAPK, a decrease in MPF activity induced the contraction of the
ring also by activating RhoA.
Results
Demecolcine-induced ooplasmic protrusion was
associated with activation of both MPF and MAPK
Aftera30-mintreatmentwith0.8 ng/mldemecolcine,85%ofthe
goat oocytes showed ooplasmic protrusions with a condensed
chromosome mass (Figure 1A and A’). While all the oocytes with
protrusions (n=40) showed a disintegrated spindle and an actin-
enriched ring around the condensed chromosome mass (Figure 1B),
spindles were disintegrated but no actin ring was observed in oocytes
without protrusions (Figure 1C). Compared to that in control
oocytes, while both MPF and MAPK activities increased signifi-
cantly inoocyteswith protrusions,onlythe MPF activityincreasedin
oocytes without protrusionsafter demecolcine treatment (Figure 2A).
Demecolcine induced ooplasmic protrusion by
increasing MPF and MAPK activities by activating MAD2
While over 80% of the oocytes treated with demecolcine,
MG132 (5-mM) or caffeine (1-mM) formed protrusions in the
absence of ROS, less than 5% did in the presence of 400-mM
ROS. While both MPF and MAPK activities increased
significantly in oocytes with protrusions, neither increased
when protrusion was inhibited by ROS (Figure 2A). In contrast
to those in demecolcine-treated oocytes, spindles in the
MG132- or caffeine-treated oocytes were not disintegrated
(Figure 1D and E). While 95% of the demecolcine-treated
oocytes were MAD2-postive (Figure 1F), all the oocytes with
MG132- or caffeine-induced protrusions were MAD2-negative
(Figure 1G). Injection of anti-MAD2 antibodies decreased
protrusion (23%) and inhibited activation of both MPF and
MAPK (Figure 2B) in the demecolcine-treated, but not in
MG132-treated oocytes.
Figure 1. Photographs of goat oocytes after different treatments to induce ooplasmic protrusions. A and A’ are the same oocyte
observed under phase contrast and fluorescence microscope, respectively, after Hoechst staining. B to K are confocal micrographs, of which, B to E
and H to K are merged images with DNA colored blue, a-tubulin green and actin red while F and G with DNA colored red while the activated MAD2
green. A and B show oocytes with protrusions while C shows an oocyte without protrusion after demecolcine treatment. D and E are oocytes with
protrusions after treatment with MG132 and caffeine, respectively. F and G are oocytes MAD2-positive and -negative after demecolcine and MG132
treatment, respectively. H and I show D+U- and M+U-treated oocytes with spindles disassembled and intact, respectively. J and K are OA.5h oocytes
without protrusion and OA4h oocytes with protrusion, respectively, both showing actin enrichment. Arrow: intact or disintegrated spindles; *: Pb1.
The scale bar is 30-mm in A–E and H–K but 70-mm in F and G.
doi:10.1371/journal.pone.0012706.g001
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activities
When oocytes were treated with demecolcine, MG132 or
caffeine in the presence of 20-mM U0126, protrusion was inhibited
(,7%); while MPF activities increased, the MAPK activity did not
(Figure 2C). Spindles were disassembled in demecolcine+U0126
treated oocytes (Figure 1H) but intact in the MG132+U0126
treated oocytes (Figure 1I). While only 23% of the oocytes formed
protrusions when treated with 0.5-mM OA for 0.5 h (OA.5h), 78%
did when treated with 0.1-mM OA for 4 h (OA4h). In oocytes
without protrusions after OA.5h treatment, while the MPF activity
did not change, MAPK activities increased significantly
(Figure 2C). In oocytes with protrusions after an OA4h treatment,
however, both kinase activities increased. The OA.5h oocytes
without protrusions showed actin enrichment and intact spindles
(Figure 1J). Although both ROS and U0126 inhibited protrusion
in the OA4h oocytes (,6%), ROS prevented activation of only the
MPF activity while U0126 inhibited both MAPK and MPF
(Figure 2C). The results suggested that (1) MPF induced ooplasmic
protrusion by increasing MAPK activities and (2) OA activated
MPF by way of MAPK.
MPF activates MAPK by way of RhoA during ooplasmic
protrusion
When oocytes were treated with demecolcine, MG132 or
caffeine in the presence of 400-mM Y27632 (inhibitor for Rho-
kinase ROCK), protrusion was inhibited (10%), and while MPF
activities increased, the MAPK activity was unchanged
(Figure 2D). Treatments that increased both MPF and MAPK
activities (D and OA4h) activated RhoA (Figure 2E); treatments
that increased MPF but not MAPK activities did not activate
RhoA (D- and AD-); and treatment that did not increase MPF
Figure 2. Relative MPF and MAPK activities (A to D) and RhoA-GTP levels (E) in oocytes after different treatments. In figures A to D,
black and gray bars represent MPF and MAPK activities, respectively. MII: Freshly matured oocytes; D and D-: Oocytes with and without protrusion
respectively after demecolcine; AD-: Aged oocytes without protrusion after demecolcine; +: In the presence of; R: ROS; U: U0126; Y: Y27632; OA.5h
and OA4h: OA for 0.5 and 4 h respectively; MD2: MAD2. a–d: Values without a common letter above their bars differ (P,0.05) within enzyme
activities.
doi:10.1371/journal.pone.0012706.g002
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activities (OA.5h and OA4h+R) or not (D+R). RhoA was activated
in oocytes treated with demecolcine and U0126 (D+U) though
their MAPK activation was inhibited. This suggested that (1) MPF
activated MAPK by way of RhoA during ooplasmic protrusion
and (2) OA activated while U0126 inactivated MAPK downstream
of RhoA.
Interactions between MPF, MAPK and RhoA during the
assembly of actomyosin rings
Treatment with 40-mg/ml CB (actin inhibitor) or 200-mM
blebbistatin (myosin II inhibitor) completely inhibited demecol-
cine- or MG132-induced ooplasmic protrusion. While oocytes
with protrusions always showed enrichment of both actin and
myosin in the protruding domain (Figure 3), oocytes without
protrusions showed either only actin enrichment (D+Bleb) or
neither actin- nor myosin-enrichment (D+CB). Treatments that
inhibited both MPF and MAPK (D+R) or MAPK alone (D+U)
prevented enrichment of both myosin and actin, whereas
treatment that inhibited MPF while activating MAPK (OA.5h)
allowed actin but not myosin enrichment. Neither actin nor
myosin was enriched in oocytes without protrusions after
demecolcine+Y27632 treatment (data not shown). When oocytes
were treated with MG132 in the presence of OA and Y27632
(M+Y+OA), both MPF and MAPK activities increased
(Figure 2D), but protrusion was inhibited (7%) and only actin
enriched while myosin did not (data not shown). The results
suggested that (1) OA activated MAPK downstream of ROCK; (2)
while MAPK promoted actin enrichment on its own, MPF
promoted myosin enrichment in a ROCK- and MAPK-depen-
dent manner.
Chromatin is essential for chemical induction of
actomyosin assembly
While injection of mouse sperm tails had no effect, injection of
mouse sperm head into intact goat oocytes induced a second
ooplasmic protrusion (Figure 4A and A’) in about half of the
injected oocytes after treatment with demecolcine (Figure 4B) or
MG132 (Figure 4C). The oocyte spindle is disintegrated after
demecolcine but intact after MG132 treatment. When mouse
sperm heads were injected into enucleated oocytes, however,
protrusion was observed only after MG132 (Figure 4D) but not
demecolcine treatment (Figure 4E).The MPF and MAPK activities
increased significantly in intact but not in enucleated oocytes after
sperm head injection and demecolcine treatment (Figure 4F). No
protrusion formed when enucleated oocytes were treated with
MG132 although both MPF and MAPK activities increased
significantly. The results suggested that ooplasmic protrusion
required interactions between chromatin and the signaling events
and the role of chromatin in inducing actomyosin assembly was
non-species-specific.
Interactions between MPF, MAPK and RhoA during the
constriction of actomyosin rings
Contraction of the actomyosin ring (Figure 5B and E) began at
0.5 and 1 h while extrusion of Pb2 (Figure 5A and D) was
observed at 1 and 2 h after chemical activation of oocytes with
demecolcine-induced protrusions and the control MII oocytes,
respectively. While the Pb2 in control oocytes were extruded with
half of the chromosome complement with the other half left inside
the oocyte (Figure 5D’ and F), the demecolcine-induced
protrusions were pinched off with the whole complement of
chromosomes (Figure 5A’ and C). While 63% of the demecolcine-
treated and 87% of the control oocytes released Pb2 after chemical
activation in the absence of Y27632, the percentage decreased to
4% and 12%, respectively, in the presence of Y27632. While MPF
activities declined to the lowest level at the time when the ring
began to contract, the MAPK activity remained high until the
time for Pb2 extrusion in both demecolcine-treated and control
oocytes (Figure 5G). Y27632 affected neither the MPF nor MAPK
dynamics. RhoA-GTP increased to the highest level at the time for
ring contraction but decreased to the basal level by the time for
Pb2 extrusion in both oocyte groups (Figure 5H).
Discussion
In this study, both MPF and MAPK activities increased
significantly in oocytes with protrusions after demecolcine
treatment. While injection of mouse sperm head into intact goat
oocytes induced a second ooplasmic protrusion and a significant
increase in both MPF and MAPK activities, injection into
enucleated oocytes had no effect after demecolcine treatment.
Furthermore, while MG132 or caffeine induced ooplasmic
protrusion without destroying spindles, treatment with ROS
inhibited protrusion in oocytes with demecolcine-disassembled
spindles. The results strongly suggest that demecolcine induces
ooplasmic protrusion by destroying the oocyte spindle and
activating MPF and MAPK. Studies in somatic cells also indicated
that treatment with microtubule-interacting agents increased MPF
activities [23–25]. In this study, while 95% of the demecolcine-
treated oocytes were MAD2-postive and injection of anti-MAD2
antibodies inhibited ooplasmic protrusion and activation of MPF
and MAPK, all of the oocytes with MG132-induced protrusions
were MAD2-negative and injection of anti-MAD2 antibodies had
no effect. It was shown that defects in spindle assembly or spindle-
kinetochore attachment, or artificial depolymerization of micro-
tubules, activated the mitotic checkpoint, which arrested cells prior
to the metaphase-anaphase transition with unsegregated chromo-
somes, stable cyclin B and elevated MPF activity [26,27]. Further
studies confirmed that MAD2 activated MPF mainly by
preventing cyclin B proteolysis [23,24,28,29].
Although studies suggest activation of MAPK family members
by microtubule inhibitors in somatic cells [30–32], it has rarely
been studied in the oocyte [22,33]. Furthermore, the mechanism
by which microtubule dysfunction activates MAPK is unknown. In
this study, while treatments that activated both MPF and MAPK
induced ooplasmic protrusion, treatments that activated MPF
while inhibited MAPK activation did not (Table 1). In both freshly
matured and aged oocytes without protrusions after demecolcine
treatment, while MPF activities increased, MAPK activity did not.
MG132 and caffeine which are known to specifically activate MPF
increased activities of both MPF and MAPK. Furthermore, while
treatment with ROS (specific CDK1 inhibitor) inhibited activation
of MAPK as well, treatment with U0126 (specific inhibitor of
MEK1/2) inhibited only MAPK. While some studies showed that
MPF triggered activation of MAPK [34–36], others demonstrated
a converse situation [37–40]. Studies in rodent [41–43] and goat
[44] oocytes suggest that MPF might be an upstream regulator of
the MAPK/Mos pathway during meiotic maturation. Further-
more, the possible role of MAPK in MPF activation in
mammalian oocytes was ruled out by the observation that oocytes
derived from mos-knockout mice, which are unable to activate
MAPK, display a normal pattern of MPF activation during
germinal vesicle breakdown and Pb1 emission [45]. After Pb1
emission, however, MPF cannot be properly reactivated in some of
the c-mos knockout oocytes. Thus, the present results suggested
that (1) microtubule dysfunction activated MAPK by activating
Signaling in Cytokinesis
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at the metaphase II (MII) stage of oocytes.
Among the drugs used in this study, while demecolcine
prevented proteolysis of cyclin B by activating spindle assembly
checkpoints, MG132, the specific inhibitor of proteasome catalytic
activity, prevented cyclin B degradation directly [46,47]. Caffeine
increased MPF activity by inhibiting Myt1/Wee1 and dephos-
phorylating Cdc2 [48,49]. Thus, the MPF in MII oocytes may be
activated either by cyclin B accumulation or by Cdc2 dephos-
phorylation. While treatment with OA for 0.5 h increased only
MAPK activity, OA treatment for 4 h increased MPF activity as
well in this study. Several studies indicated that OA activated MPF
as well as MAPK [41,50,51]. OA may activate MPF either directly
by inhibiting protein phosphatase 1 and 2A that would otherwise
inactivate Cdc25 [52] or indirectly by activating MAPK which
activates p90(rsk) and down-regulates Myt1 [39,40]. In this study,
when oocytes were treated with OA for 4 h, neither MPF nor
MAPK activities increased in the presence of U0126; however,
while MPF activation was inhibited, MAPK activity increased as
usual in the presence of ROS. This suggested that OA activated
MPF by activating MAPK, a situation similar to that of c-mos
knockout mouse oocytes in which MPF could not be properly
activated after first meiosis [45]. Together, the results suggest that
in MII oocytes, MPF and MAPK can each activate the other
depending on circumstances.
However, the mechanism by which MPF activates MAPK has
not been reported. In this study, when oocytes were treated with
demecolcine, MG132 or caffeine in the presence of the ROCK
inhibitor Y27632, protrusion and MAPK activation was blocked
while the MPF activity increased as usual (Table 1). Furthermore,
RhoA-GTP assay confirmed that the elevated MPF activities
activated RhoA which then activated MAPK during ooplasmic
protrusion. In keeping with the present results, studies using
somatic cells indicated that microtubule minimization or depoly-
merization activated RhoA [2,3], and that Rho GTPase activated
components in the MAPK signaling pathway [53–56]. In Xenopus
oocytes, Rho-associated protein kinase alpha potentiated insulin-
induced MAPK activation [57]. However, Rho activation by
increased MPF activities has not been reported, but on the
contrary, a decrease in MPF activities was found to activate RhoA
by activating the guanine nucleotide exchange factor (GEFs) in
both somatic cells [58,59] and mouse oocytes [60].
Since Elbaz et al. [60] also observed that many of the ECT2
(GEFs) depleted oocytes that failed to extrude Pb1 displayed an
elongated protrusion reminiscent of the induced ooplasmic
protrusion of this study, we postulated that the recruitment of
actin and myosin into contractile rings and the contraction of the
ring might be two separate steps involving different regulation
mechanisms; while the contraction requires activated ECT2 for
RhoA activation, assembly of the ring might be regulated by a
Figure 4. Ooplasmic protrusion and MPF/MAPK activities after oocytes were injected with mouse sperm head (SP) and treated with
demecolcine or MG132. A and A’ are the same oocyte observed under phase contrast and fluorescent microscopes, respectively, showing the egg
chromosome-induced protrusion (arrow), SP-induced protrusion (arrowhead) and Pb1 (*). B to E show confocal images with DNA colored blue, a-
tubulin green and actin red. B and C: Oocytes with both egg chromosome- and SP-induced protrusions after demecolcine and MG132 treatment,
respectively. D and E: Enucleated oocytes injected with SP formed protrusion after MG132 (D) but did not after demecolcine (E). Scale bar is 20 mm. F:
Relative MPF/MAPK activities after intact (MII) or enucleated oocytes (EnMII) were injected with SP (+SP) and treated with demecolcine (+SP+D) or
MG132 (+M). Values without a common letter above their bars differ (P,0.05) within kinase activities.
doi:10.1371/journal.pone.0012706.g004
Figure 3. Confocal micrographs of oocytes showing enrichment of actin and/or myosin (arrow) after different treatments. Myosin is
shown in green, actin in red and DNA in blue. Treatments include demecolcine (D), MG132 (M) or OA for 0.5 h (OA.5h) alone or demecolcine +
Blebbistatin (Bleb), Cytochalasin B (CB), U0126 (U) or ROS (R). *: Pb1. Scale bar is 30 mm.
doi:10.1371/journal.pone.0012706.g003
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have shown that CDK/cyclin complex promotes actin polariza-
tion for hyphal growth by inhibitory phosphorylation of GTPase
activating proteins (GAPs) that would otherwise inactivate Rho
[61,62]. In this study, when goat oocytes with demecolcine-
induced protrusions were chemically activated with ionomycin
and CHX, MPF decreased while RhoA-GTP increased sharply,
and the actomyosin ring contracted and pinched off as Pb2 with
the whole complement of chromosomes. Y27632 inhibited
extrusion of Pb2 but had effects on neither the MPF nor MAPK
dynamics. This suggested that (1) RhoA activation was essential for
the constriction of actomyosin rings after oocyte activation, and (2)
while increased MPF activities activated RhoA possibly by
inactivating GAPs during the assembly, decreased MPF activities
activated RhoA probably by activating GEFs during the
constriction of the actomyosin ring. During mouse oocyte
maturation, coincident with the cortical localization of the meiotic
spindle was the formation of a microvillus- and cortical granule-
free area and a thickening of the actin layer in this region of the
egg cortex [10], and it was found that most of the mouse oocytes
completed formation of the cortical granule-free domain at the
metaphase I stage [63]. In fission yeast, while formation of the
contractile ring was completed at 30 min, contraction of the ring
was not started until 37 min after the onset of spindle pole body
separation [64].
In this study, oocytes with protrusions were always character-
ized by enrichment of both actin and myosin in the protruding
domains, and treatment with either actin or myosin inhibitor
completely inhibited ooplasmic protrusion. Requirements for
actin-myosin interactions have been reported during cytokinesis
of various cell types [7,65,66], but the signaling events involved
have not been fully elucidated. Studies using somatic cells suggest
that (1) MAPK activities are involved in the regulation of actin
reorganization [67–70]; (2) MAPK enhances myosin light chain
Figure 5. Pb2 Extrusion and activities of MPF, MAPK and RhoA after oocytes with demecolcine-induced protrusions (DIP) were
activated. A, A’ and D, D’ are the same oocyte observed under phase contrast and fluorescence microscope, respectively, after Hoechst staining. B,
C, E and F are confocal images with DNA colored blue, a-tubulin green and actin red. Contraction of the actomyosin ring began at 0.5 h (B) and 1 h
(E) while Pb2 extrusion (arrows) observed at 1 h (A, A’, C) and 2 h (D, D’, F) after chemical activation (CA) of the DIP and control MII oocytes,
respectively. *: Pb1. Scale bar is 30 mm. Panels G and H show relative MPF/MAPK and RhoA activities, respectively. MII and D: Freshly matured and DIP
oocytes prior to CA; +: In the presence of; Y: Y27632; CA.5h, CA1h and CA2h: Oocytes assayed at 0.5, 1 and 2 h of CA, respectively. a–d: Values without
a common letter above their bars differ (P,0.05) within enzyme activities.
doi:10.1371/journal.pone.0012706.g005
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(MLC) [71–73], which is important for recruitment of myosin into
the contractile ring [74]; (3) MPF activates MLC [75,76] either by
inhibiting myosin phosphatase-targeting subunit (MYPT) [77]
which would otherwise inactivate MLCK [78–80], or by
phosphorylating caldesmon which would otherwise inactivate
actomyosin ATPase [4,81]; and (4) ROCK activates myosin II by
inactivating MYPT [3]. However, interactions between MPF,
MAPK and Rho GTPase in this context have not been reported.
This study showed that while actin enrichment required only the
increase in MAPK activity during ooplasmic protrusion, myosin
enrichment required elevated activities of MPF as well as MAPK
and RhoA GTPase (Table 1), suggesting that while MAPK
controls actin recruitment on its own, MPF promotes myosin
recruitment in a RhoA- and MAPK-dependent manner during
actomyosin assembly. Since both MPF and ROCK inactivated
MYPT in somatic cells and that MPF activated RhoA in this
study, our hypothesis to explain the dependence of MPF on
MAPK and ROCK for myosin recruitment is that (1) MPF
inactivates MYPT via RhoA and (2) only when MYPT is
inactivated can the elevated MAPK activity activate MLCK and
thereby myosin II.
In this study, injection of mouse sperm head into intact goat
oocytes induced a second ooplasmic protrusion after treatment
with demecolcine or MG132. However, no protrusion formed
when enucleated oocytes were treated with MG132 although both
MPF and MAPK activities increased significantly. Thus, ooplas-
mic protrusion requires an interaction between the elevated MPF/
MAPK activities and the chromatin, which can be from a different
species. The chromosome spindle was found to determine the
localization of the actin-rich but cortical granule-free domain
during polarization of maturing mouse oocytes [10–12,15,16,82].
When the chromosomes became scattered following microtubule
disruption, however, a cortical granule-free domain was observed
over each individual chromosome [11,83]. Furthermore, mouse
sperm chromatin, even DNA-coated beads, could induce polar-
ization of mouse oocytes [12,15,16,84] after microinjection.
According to Deng and Li [84], the signals that emanate from
the sperm chromosomes to induce spindle formation and cortical
reorganization are qualitatively and quantitatively different; while
injection of loosely compact chromatin from round spermatids
induced both cortical reorganization and spindle formation,
leading to polar body extrusion, injection of highly compact
chromatin from mature spermatozoa only allowed cortical
reorganization without spindle formation and polar body
extrusion. Thus, the results show a similarity between the
chemical-induced cortical protrusion and polarization of oocytes.
To summarize the major findings of this study (Figure 6),
demecolcine activates MPF by disassembling spindle microtubules
and activating MAD2 while MG132 and caffeine activate MPF
directly. The increased MPF activity activates RhoA possibly by
inactivating GAPs. The activated RhoA activates MAPK. While
the elevated MAPK activity recruits actin on its own, the increased
MPF activity recruits myosin in a RhoA- and MAPK-dependent
manner. From data obtained in other systems, it is possible that
RhoA inactivates MYPT, which allows the activation of MLCK
by MAPK leading to the recruitment of myosin into the contractile
ring. Chromatin or DNA is essential for the assembly of
actomyosin rings. When oocytes with demecolcine-induced
protrusions were treated with ionomycin and CHX, the MPF
activity decreases, activating RhoA possibly by activating GEFs.
The active RhoA induces contraction of the ring resulting in
cytokinetic abscission of the protrusion (Pb2 extrusion).
Materials and Methods
All chemicals and reagents were purchased from Sigma
Chemical Company (St. Louis, MO, USA) unless otherwise
specified. Oocyte culture was carried out at 38.5uCi n5 %C O 2 in
humidified air, unless otherwise specified.
Collection and in vitro maturation (IVM) of oocytes
Oocytes collected from goat ovaries [22] were cultured for
maturation in droplets of TCM-199 (Gibco, Grand Island, New
Table 1. Interactions between MPF, MAPK and RhoA on enrichment of actin and myosin during ooplasmic protrusion following
different treatments of goat oocytes.
Treatments Protrusion MPF RhoA MAPK Actin enrichment Myosin enrichment Spindle integrity
D ++ + + + + 2
D22 + 222 2 2
D+U 2 ++ 22 2 2
D+Y 2 + 222 2 2
D+R 22 2 2 2 2 2
M ++ NA ++ + +
M+U 2 + NA 22 2 +
M+Y 2 + 222 2 +
M+Y+OA 2 + 2 ++ 2 +
M+R 22 NA 22 2 +
OA.5h 22 2 ++ 2 +
OA4h ++ + + + + +
OA4h+R 22 2 ++ 2 +
OA4h+U 22 NA 22 2 +
Abbreviations: D: 0.8 ng/ml demecolcine; D-: Oocytes without protrusion after D; U: 20-mM U0126; Y: 400-mM Y27632; R: 400-mM ROS; M: 5-mM MG132; C: 1-mM caffeine;
OA.5h: 0.5-mM OA for 0.5 h; OA4h: 0.1-mMO Af o r4h ;+: In the presence of; NA: Not assayed. All treatments were performed for 30 min unless otherwise specified.
doi:10.1371/journal.pone.0012706.t001
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estradiol, 24.2 mg/L sodium pyruvate, 0.05 IU/ml FSH, 0.05
IU/ml LH and 10 ng/ml EGF. At 19 h of culture, oocytes were
freed of cumulus cells and those with a first polar body (Pb1) but
without spontaneous ooplasmic protrusions were selected for
further treatments.
Treatment of oocytes to regulate the assembly and
contraction of contractile rings
To induce or inhibit ooplasmic protrusion, oocytes were
cultured in Dulbecco’s phosphate-buffered saline (D-PBS) supple-
mented with different drugs for 30 min. At the end of treatment,
oocytes were examined under a stereomicroscope and were
divided into groups with or without ooplasmic protrusions for
further treatments.
To induce contraction of the actomyosin ring, oocytes with
demecolcine-induced ooplasmic protrusions and the control
oocytes collected at 19 h of IVM were first exposed to 5-mM
ionomycin for 5 min at room temperature, and then cultured in
the CR1aa medium containing 10-mg/ml cycloheximide (CHX)
with or without 400-mM Y27632. Oocytes were observed under a
phase contrast microscope for extrusion of Pb2 or assayed for
MPF/MAPK and RhoA activities at 0.5, 1 or 2 h of culture.
Micromanipulators were used to move the Pb2 to confirm
cytokinetic abscission.
Roscovitine (ROS, 20 mM), U0126 (10 mM), okadaic acid
(OA, 100 mM), MG132 (5 mM), Y27632 (20 mM), cytochalasin B
(CB, 5 mg/ml), blebbistatin (34.2 mM) and ionomycin were
dissolved in dimethyl sulfoxide (DMSO), while demecolcine
(10 mg/ml) was dissolved in Hank’s balanced salt solution (HBSS),
caffeine (100 mM) was dissolved in D-PBS and CHX in water. All
the stock solutions were stored in aliquots at 220uC except for
demecolcine which was stored at 4uC until use.
Immunofluorescence microscopy
All the procedures were conducted at room temperature unless
otherwise specified. Oocytes were washed 3 times in D-PBS
between treatments. Oocytes were (1) freed of zona pellucida by
treatment with 0.5% pronase (Roche Diagnostics GmbH,
Mannheim, Germany) in D-PBS at 37 uC for 3–5 min; (2) fixed
with 4% paraformaldehyde in the PHEM buffer (60 mM Pipes,
25 mM Hepes, 10 mM EGTA and 4 mM MgSO4, pH 7.0) for at
least 30 min; (3) treated for 10–15 min in 1% Triton-X 100 in
PHEM; (4) blocked in PHEM containing 1% BSA and 100 mM
glycine at 4 uC overnight.
Triplestainingofa-tubulin,actinandchromatin. Blocked
oocytes were incubated (1) for 1 h in PHEM containing fluorescein
isothiocyanate (FITC)-conjugated anti-a-tubulin monoclonal
antibodies (1:50) to stain tubulin; (2) for 1 h in PHEM con-
tainingtetramethylrhodamineB isothiocynate (TRITC)-conjugated
phalloidin (1:200) to label actin; (3) for 15 min in D-PBS with
10 mg/ml Hoechst 33342 to stain chromosomes.
Double staining of MAD2 and chromatin. Blocked oocytes
were incubated (1) overnight in rabbit anti-MAD2 antibody (1:50,
Santa Cruz, Biotechnology, Inc.) in 1% BSA/PHEM with
100 mM glycine at 4uC; (2) for 1 h with FITC-conjugated goat-
anti-rabbit IgG (1:200, Santa Cruz, Biotechnology, Inc.) in 1%
BSA/PHEM with 100 mM glycine; (3) for 15 min in D-PBS with
10-mg/ml propidium iodide to stain chromosomes.
Triple staining of myosin IIA, actin and chromatin.
Blocked oocytes were incubated (1) for 2 h in rabbit anti-
myosin IIA antibody (1:50, Santa Cruz, Biotechnology, Inc.) in
1% BSA/PHEM with 100 mM glycine; (2) for 1 h with FITC-
conjugated goat-anti-rabbit IgG (1:200) in 1% BSA/PHEM with
100 mM glycine; (3) for 1 h to stain actin as described above; (4)
for 15 min in D-PBS with 10 mg/ml Hoechst 33342 to stain
chromosomes.
Figure 6. The signaling pathways leading to the assembly and contraction of actomyosin rings during chemical-induced oocyte
cytokinesis. Refer to the text for detailed explanations.
doi:10.1371/journal.pone.0012706.g006
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mounted on glass slides and observed with a Leica laser
scanning confocal microscope. Hoechst 33342 labeled chromatin
was excited with the 405 nm line of a diode laser. The FITC/PI
and TRITC fluorescence was obtained by excitation with 488 and
533 nm lines of an Ar/ArHr laser and the emitted light was passed
through 488 and 533 nm filters, respectively. The individual
optical sections were pseudo-colored and digitally recombined
when necessary into a single composite image using the Leica
Confocal Software.
Histone H1 and MAP kinase assay
Ten oocytes from each treatment were washed 3 times in the
kinase buffer (15-mM 3-[n-morpholino] propanesulfonic acid
[MOPS], pH 7.2, containing 80-mM glycerophosphate, 10-mM
EGTA, 15-mM MgCl2, 0.1-mM PMSF, 10 mg/ml leupeptin,
10 mg/ml aprotinin, and 10 mg/ml cAMP-dependent protein
kinase inhibitor peptide), transferred to10-ml kinase buffer
contained in a 1.5 ml microfuge tube and stored frozen at
270uC. The frozen samples were subjected to 4 to 5 times freezing
and thawing to prepare lysates. Kinase reactions were initiated by
the addition of 10-m1 substrate buffer containing 2 mg/ml histone
H1 or 1 mg/ml myelin basic protein (MPB), 2-mM dithiothreitol
(DTT) and 20-mCi/ml [c-
32P] ATP to each sample. The reactions
were carried out for 50 min at 36uC and terminated by the
addition of an equal volume of double-strength SDS sample buffer
containing b-mercaptoethanol. Kinase reaction products were
boiled for 3 min and separated by 12% linear gradient SDS-
PAGE. Gels were exposed to phosphor-screens. Data acquisition
was the actual scanning of sample images with the CycloneH Plus
Storage Phosphor System to create an image file that can be
analyzed by the OptiQuant
TM Image Analysis Software. The
kinase activity values of newly matured goat oocytes collected 19 h
of IVM were arbitrarily set as 100%, and the other values were
expressed relative to this activity. The amount of kinase reaction
product used for SDS-PAGE was strictly controlled (20 ml) for
each sample, and three samples were analyzed for each treatment.
Microinjection of anti-MAD2 antibodies into goat
oocytes
Microinjection of anti-MAD2 antibodies was performed in D-
PBS using a Leica inverted microscope equipped with two
micromanipulators. A goat oocyte was held to the holding pipette
at the 9 o’clock position and then rotated until the oocyte side with
Pb1 was around the 12 o’clock position. The injection pipette (4-
mm in inner diameter with a beveled fine point) containing
antibodies was positioned at the 3 o’clock position and advanced
to penetrate the zona pellucida and the oolemma. Once inside the
oolemma, a volume of about 30-pl of the antibodies (0.2 mg/ml in
D-PBS) was injected into the oocyte. Control oocytes were injected
with the same volume of goat IgG (0.5 mg/ml in D-PBS) or D-
PBS. After injection, oocytes were cultured for 30 min in
maturation medium before treatments to induce ooplasmic
protrusions.
Rho-GTPase activity assay
From each treatment, 150 or 50 oocytes were collected for
RhoA-GTP or total RhoA analysis, respectively. Oocytes were (1)
washed 3 times in a sample buffer containing 50-mM Tris
pH 7.2, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1%
SDS, 60-mM n-octyl glucopyranoside, 500-mM NaCl, 10-mM
MgCl2,1 0 mg/ml leupeptin, 10 mg/ml aprotinin and 1-mM
phenylmethylsulphonyl fluoride (PMSF); (2) transferred to a 0.2-
ml microfuge tube with 20-ml buffer and lysated by 3–5 times
freezing and thawing; (3) lysates were incubated with 5-mgo fa
glutathione-agarose bound GST-tagged rhotekin Rho binding
domain (Upstate Biotechnology in USA) at 4uC for 45 min with
gentle rocking; (4) beads were collected by centrifugation at
15,000 rpm for 30s at 4uC and washed twice in the sample buffer;
(5) 15-ml sample buffer containing beads in each tube were frozen
at 270uC; (6) frozen beads were resuspended in 15-mlo f
26Laemmli sample buffer, boiled for 5 min and separated by
12% linear gradient SDS-PAGE; (7) the protein samples were
transferred onto PVDF membranes in transferring buffer
containing 0.1M Tris, 0.192M glycin and 5% methanol in
TBST (TBS with 0.1% Tween 20) at 2mA/cm
2 for 30 min with
AE-6675 HorizBlot (ATTO corporation in Japan); (8) mem-
branes were blocked for 1 h with TBST containing 3% BSA and
incubated with (a) anti-RhoA antibody (1:500 dilution, Abcam in
UK) in TBST with 3% BSA at 4uC overnight, (b) horseradish
peroxidase-conjugated antibody (1:1000 dilution, Sizheng Bio-
technology, China) in TBST/3% BSA for 1 h and (c) Immobilon
Western reagent (Millipore Corporation in USA); (9) membranes
were exposed to x-ray film. The relative quantity of RhoA-GTP
was determined with Image-Pro Plus Software by analyzing the
sum density of each protein band image. The quantity values of
newly matured oocytes collected 19 h of IVM were arbitrarily set
as 100%, and the other values were expressed relative to this
activity. b-actin in each sample was also analyzed as control using
the anti-b-actin antibody. Total lysate was immunoblotted with
the same RhoA antibody to illustrate equality in oocyte RhoA
across conditions.
Microinjection of mouse sperm heads or tails into goat
oocytes
Masses of dense sperm were collected from mouse caudae
epididymides [85] and placed in a test tube containing 500-mlD -
PBS. After mixing, the resulting sperm suspension was sonicated
for 5 min to separate sperm heads from the tails. The suspension
was then heated in a water bath at 60–65uC for 40 min and 1:1
diluted in D-PBS before microinjection. The Pb1 and 1/5–1/4 of
the ooplasm underneath were removed from some oocytes using
an enucleation pipette (25 mm in inner diameter). To inject sperm
heads or tails, an oocyte was held to the holding pipette at the 9
o’clock position and then rotated until the oocyte side with Pb1
was around the 12 o’clock position. The injection pipette (8–
10 mm in inner diameter) containing a sperm head or a tail was
advanced to penetrate the zona and the oolemma at the 3 o’clock
position. Care was taken to place sperm heads or tails into the egg
cortex as close to the plasma membrane as possible. After
microinjection, the oocytes were cultured for 30 min in matura-
tion medium before treatment for protrusion induction.
Data analysis
There were at least three replicates for each treatment.
Percentage data were arc sine transformed and analyzed with
ANOVA; a Duncan multiple comparison test was conducted to
locate differences. The soft ware used was Statistics Package for
Social Science (SPSS 11.5, Chicago, IL, USA). Data were
expressed as mean 6 SE and P,0.05 was considered significant.
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